Skip to content

Acadia Pharmaceuticals ACAD Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin91.5%-0.6pp91.7%+0.2pp91.9%+0.3pp92%+0.2pp92%-0.2pp
Operating margin7.4%9.8%23%
Net margin34.3%+11.3pp36.5%+12.8pp24.9%+11.1pp21.8%+18.4pp23%+23.2pp
Returns
Return on equity37.3%+0.1pp39.9%+1.0pp35%+7.6pp33.2%+26.5pp37.2%+37.6pp
Return on invested capital10%13.4%38.8%
Efficiency
Asset turnover0.8×-0.2×0.8×-0.2×0.9×-0.2×-0.2×-0.1×
Liquidity
Current ratio3.6×+0.7×3.8×+1.5×+0.7×2.9×+0.8×2.9×+0.8×
Leverage
Debt-to-equity0.0×0.0×0.1×0.0×0.1×0.0×0.1×-0.1×
Net debt / EBITDA-2.5×-1.1×-0.8×
Per Share
Book value per share$7.23+58.3%$7.22+64.0%$5.38+54.8%$4.88+56.8%$4.56+63.9%
Valuation
Market capitalization$3.8B+37.0%$4.52B+48.0%$3.6B+41.1%$3.75B+39.7%$2.77B-9.1%
Price / earnings10.1×-2.0×11.6×13.8×16.9×12.1×
Price / sales3.5×+0.7×4.2×+1.0×3.4×+0.7×3.7×+0.7×2.8×-1.0×
Price / book-0.6×3.7×-0.5×3.9×-0.5×4.6×-0.6×3.6×-2.9×
EV / EBITDA38.4×37.7×13.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Acadia Pharmaceuticals's profit margins?
Acadia Pharmaceuticals (ACAD) runs a 91.5% gross margin and a 7.4% operating margin, with a 34.3% net margin.
Where do Acadia Pharmaceuticals's ratios come from?
Every ratio is computed from Acadia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.